BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report)’s stock price was down 6.7% during mid-day trading on Friday . The stock traded as low as $0.2141 and last traded at $0.2430. Approximately 1,578 shares were traded during trading, an increase of 36% from the average daily volume of 1,160 shares. The stock had previously closed at $0.2605.
BioNxt Solutions Stock Performance
The firm has a market capitalization of $33.07 million, a P/E ratio of -4.86 and a beta of 0.75. The firm has a 50 day simple moving average of $0.24 and a two-hundred day simple moving average of $0.30.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its earnings results on Friday, August 28th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc is a biotechnology company focused on developing pharmaceutical and drug-delivery technologies. Its work centers on alternative dosage forms designed to improve the administration, absorption, and convenience of medicines, including oral dissolvable and sublingual films, transdermal systems, and other novel delivery platforms.
The company’s development activities have included pharmaceutical products and delivery systems targeting areas such as neurological disorders and other medical conditions.
Read More
- Five stocks we like better than BioNxt Solutions
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
